M11.052
Hydroxyapatite deposition disease, left hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Hydroxyapatite Deposition Disease (HADD) is a condition characterized by the abnormal accumulation of hydroxyapatite crystals in soft tissues, particularly around joints. When these deposits occur in the left hip, they can cause significant discomfort and functional limitations. This condition is identified under the ICD-10 code M11.052, indicating its specific location and nature. Understanding the causes, symptoms, and potential treatments can help in managing this condition effectively.
Causes & Symptoms
Clinical Causes: Degenerative changes in the joint tissue leading to crystal formation Repetitive stress or trauma to the hip area, prompting crystal deposits Aging process, which can alter tissue metabolism and promote crystal formation Underlying metabolic disorders that affect mineralization processes Genetic predisposition influencing tissue mineralization tendencies
Key Symptoms: Localized pain in the left hip, which may worsen with movement or activity Swelling or tenderness around the hip joint Limited range of motion in the affected hip Crepitus or a grating sensation during hip movement Possible radiating pain into the thigh or groin area Occasional warmth or redness over the joint
Diagnostic & Treatment
Diagnosis Path: X-ray imaging, which can reveal radiopaque deposits characteristic of hydroxyapatite crystals Ultrasound scans to detect soft tissue calcifications Magnetic Resonance Imaging (MRI), providing detailed visualization of soft tissue structures Laboratory tests may be conducted to rule out other causes of joint pain, although no specific blood test confirms HADD
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to relieve pain and inflammation Rest and activity modification to avoid aggravating movements Physical therapy to improve joint mobility and strengthen surrounding muscles Corticosteroid injections directly into the affected area for severe inflammation Extracorporeal shock wave therapy, which in some cases can promote the dissolution of deposits Surgical intervention, such as removal of calcific deposits, may be considered if conservative treatments fail
Clinical Advice & FAQs
Billing Guidance
Is M11.052 a billable ICD-10 code?
Yes, M11.052 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.052?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, left hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference